Alison Oliver

Alison Oliver joined Innomar Strategies in 2016 as Senior Director, InnomarConsulting and transitioned to Senior Director of Customer Experience, Rare Diseases in 2022. She began her career in the fields of communication and marketing over 15 years ago, then moved to specialize in government relations, health economics and market access at Becton Dickinson and Baxter. Alison has experience in multiple therapeutic areas such as diabetes, oncology, diagnostics and hemophilia where she worked to examine how the clinical and economic impact of pharmaceuticals and diagnostics could remove market access barriers for patients and clinicians. Alison’s market access and health economics experience provides her with a solid foundation to evaluate and understand how the Canadian healthcare system can examine outcomes to ensure universal access and best practices around therapy.

Today, Alison’s expertise is being leveraged within her current role with our patient support programs (PSPs), where she oversees over 55 rare disease portfolios, focusing on commercialization, real world evidence and reimbursement initiatives.